<?xml version="1.0" encoding="UTF-8"?>
<p>Malignant MatLyLu (R33327) prostate cancer and Walker 256/B (W256) mammary gland cancer cells were used to test the in vitro anticancer activity of 
 <italic>T. polium</italic> extract. These two cell lines were kindly provided by Prof. D. Chappard (Angers, France) to Dr. R. Badraoui (Sfax, Tunisia). MatLyLu and Walker 256/B malignant cells have a high osteolylic potential and are commonly used to induce osteosclerotic or osteolytic tumor lesions following the protocols previously described by Badraoui et al. [
 <xref rid="B48-antioxidants-09-01089" ref-type="bibr">48</xref>,
 <xref rid="B49-antioxidants-09-01089" ref-type="bibr">49</xref>].
</p>
